Advertisement

Journal of Nuclear Cardiology

, Volume 11, Issue 2, pp 171–185 | Cite as

Prognostic value of gated myocardial perfusion SPECT

  • Leslee J. Shaw
  • Ami E. Iskandrian
Major achievements in nuclear cardiology: III

Keywords

Cardiol Single Photon Emission Compute Tomography Myocardial Perfusion Myocardial Perfusion Imaging Nuclear Cardiology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Available at American Heart Association Web site: http://www. americanheart.org/statistics/economic.html. Accessed December 10, 2003.Google Scholar
  2. 2.
    Levin DC, Parker L, Intenzo CM, Sunshine JH. Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures: 1996–1998 practice patterns. Radiology 2002;222:144–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Mark DB, Shaw LJ, Lauer MS, O’Malley P, Heidenreich P. 34th Bethesda Conference: Task force #5-is atherosclerotic imaging cost effective? J Am Coll Cardiol 2003;41:1906–17.PubMedCrossRefGoogle Scholar
  4. 4.
    Available at American College of Cardiology Web site: http:// www.acc.org/advocacy/advoc_issues/impactchart.htm. Accessed December 10, 2003.Google Scholar
  5. 5.
    Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: the evidenceA consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists. Eur J Nucl Med Mol Imaging 2003;31:261–91.PubMedCentralCrossRefGoogle Scholar
  6. 6.
    Berman DS, Shaw LJ, Germano G. Nuclear cardiology. In: Fuster V, Alexander RW, O’Rourke RA, editors. Hurst’s the heart. 10th ed. New York: McGraw-Hill; 2001. p. 525–65.Google Scholar
  7. 7.
    Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration [published erratum appears in Lancet 1994;344:1446]. Lancet 1994;344:563–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. Stratification of patients into high, medium, and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:964–1047.CrossRefGoogle Scholar
  9. 9.
    Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intensive lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003;41:263–72.PubMedCrossRefGoogle Scholar
  10. 10.
    Parisi AF, Hartigan PM, Folland ED. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) study. J Am Coll Cardiol 1997;30:1256–63.PubMedCrossRefGoogle Scholar
  11. 11.
    O’Rourke RA, Chaudhuri T, Shaw L, Berman DS. Resolution of stress-induced myocardial ischemia during aggressive medical therapy as demonstrated by single photon emission computed tomography imaging. Circulation 2001;103:2315.PubMedCrossRefGoogle Scholar
  12. 12.
    Mostaza JM, Gomez MV, Gallardo F, et al. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels. J Am Coll Cardiol 2000;35:76–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994;24:25–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Yokoyama I, Ohtake T, Momomura S, et al. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996;94:3232–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Zeiher AM, Krause T, Schachinger V. et al. Impaired endothelium- dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991;121:1361–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Stegaru B, Loose R, Keller H, Buss J, Wetzel E. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion. Am J Cardiol 1988;61:74E-7E.PubMedCrossRefGoogle Scholar
  18. 18.
    Zacca NM, Verani MS, Chahine RA, Miller RR. Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina. Am J Cardiol 1982; 50:689–95.PubMedCrossRefGoogle Scholar
  19. 19.
    Sharir T, Rabinowitz B, Chouraqui P. Anti-ischemic drugs reduce size of reversible defects in dipyridamole/submaximal exercise TI-201 SPECT imaging [abstract]. J Nucl Cardiol 1997;4:S71.CrossRefGoogle Scholar
  20. 20.
    Shehata AR, Mascitelli VA, Herman SD, et al. Impact of acute propanolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997;80:268–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Cid E, Mahmarian JJ. Factors affecting the diagnostic accuracy of quantitative single photon tomography combined with dobutamine stress [abstract]. J Nucl Med 1996;37:58P.Google Scholar
  22. 22.
    Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995;274:894- 901.PubMedCrossRefGoogle Scholar
  23. 23.
    Gould KL. Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease. Circulation 1994;90:1558–71.PubMedCrossRefGoogle Scholar
  24. 24.
    Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol 1995;76: 122A-5A.PubMedCrossRefGoogle Scholar
  25. 25.
    Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998;98:2017- 23.PubMedCrossRefGoogle Scholar
  26. 26.
    Lewin HC, Berman DS. Achieving sustained improvement in myocardial perfusion: role of isosorbide mononitrate. Am J Cardiol 1997;79:31–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Hayes SW, Shaw LJ, O’Rourke RA, et al, COURAGE Investigators. Relationship between clinical site and core lab assessments of perfusion and function on stress gated myocardial perfusion SPECT. J Am Coll Cardiol 2001;37:438A.CrossRefGoogle Scholar
  28. 28.
    Boden WE, Weintraub WS, O’Rourke RA, et al. Review of the trials comparing medical therapy versus angioplasty and the rationale/design of the clinical outcomes utilizing percutaneous coronary revascularization and aggressive drug evaluation (COURAGE) trial. Am Heart J. In press 2004.Google Scholar
  29. 29.
    Mahmarian JJ, Moye LA, Verani MS, Bloom MF, Pratt CM. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography. Am J Cardiol 1995;75:1116–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Iskander S, Pratt CM, Filipchuk NG, et al. Medical and revascularization therapies for suppression of post-infarction myocardial ischemia. Preliminary results from the Adenosine Sestamibi Post-Infarction Evaluation (INSPIRE) trial [abstract]. Circulation 2001;104:II-455.Google Scholar
  31. 31.
    Schwartz RG, Pearson TA, Kalaria VG, et al. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastastin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol 2003;42:600–10.PubMedCrossRefGoogle Scholar
  32. 32.
    Abrams J, Pasternak R, Greenland P, Houston-Miller N, Smaha L. Bethesda Conference #34: identification of CHD and CHD risk: is there a detection gap? J Am Coll Cardiol 2003;41:1863- 74.PubMedCrossRefGoogle Scholar
  33. 33.
    Shaw LJ, Hendel R, Lauer MS, et al, for the Myoview Multicenter Registry. Prognostic value of normal exercise and adenosine Tc-99m tetrofosmin SPECT imaging: results from the multicenter registry in 4,728 patients. J Nucl Med 2003; 44:134–9.PubMedGoogle Scholar
  34. 34.
    Available at European Society of Cardiology: www.escardio.org/ scinfo/Guidelines/98prevention.pdf. Accessed December 10, 2003.Google Scholar
  35. 35.
    Pasternak RC, Abrams J, Greenland P, et al. Taskforce #1-identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 2003;41:1863–74.PubMedCrossRefGoogle Scholar
  36. 36.
    Available at NIH-NHLBI: http://hin.nhlbi.nih.gov/atpiii/calculator. asp?usertype_prof. Accessed December 10, 2003.Google Scholar
  37. 37.
    Berry E, Kelly S, Hutton J, et al. A systematic literature review of spiral and electron beam computed tomography: with particular reference to clinical applications in hepatic lesions, pulmonary embolus and coronary artery disease. Health Tech Assess 1999; 3:1–121.Google Scholar
  38. 38.
    O’Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000;102:126–40.PubMedCrossRefGoogle Scholar
  39. 39.
    Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology- National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol 2002;39:1104–12.PubMedCrossRefGoogle Scholar
  40. 40.
    DeLong ER, Nelson CL, Wong JB, et al. Using observational data to estimate prognosis: an example using a coronary artery disease registry. Stat Med 2001;20:2505–32.PubMedCrossRefGoogle Scholar
  41. 41.
    Shaw LJ, Eisenstein EL, Hachamovitch R, et al. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: part II.J Nucl Cardiol 1997;4:52–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958;53:457–81.CrossRefGoogle Scholar
  43. 43.
    Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: John Wiley and Sons, Inc; 1999.Google Scholar
  44. 44.
    Cox D. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187–220.Google Scholar
  45. 45.
    Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201–10.PubMedCrossRefGoogle Scholar
  46. 46.
    Goldman L, Mudge GH Jr, Cook EF. The changing “natural history” of symptomatic coronary artery disease: basis versus bias. Am J Cardiol 1983;51:449–54.PubMedCrossRefGoogle Scholar
  47. 47.
    Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757–63.PubMedCrossRefGoogle Scholar
  48. 48.
    Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618–20.PubMedCrossRefGoogle Scholar
  49. 49.
    Gjorup T, Kelbaek H, Stenbygard L, et al. Effect of knowledge of serum enzyme concentrations on doctors’ interpretation of electrocardiographic manifestations in suspected myocardial infarction. Br Med J (Clin Res Ed) 1986;292:27.CrossRefGoogle Scholar
  50. 50.
    Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol 2001;37:1558–64.PubMedCrossRefGoogle Scholar
  51. 51.
    Pearson TA. New tools for coronary risk assessment. Circulation 2002;105:886–92.PubMedCrossRefGoogle Scholar
  52. 52.
    Arnell TD, de Virgilio C, Donayre C, et al. Abdominal aortic aneurysm screening in elderly males with atherosclerosis: the value of physical exam. Am Surg 1996;62:861–4.PubMedGoogle Scholar
  53. 53.
    Shaw LJ, Berman DS, Hachamovitch R, et al. Noninvasive strategies for the estimation of cardiac risk: an observational assessment of outcome in stable chest pain patients. Am J Cardiol 2000;86:1–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Elhendy A, Schinkel A, Bax JJ, van Domburg RT, Poldermans D. Long-term prognosis after a normal exercise stress Tc-99 sestamibi SPECT study. J Nucl Cardiol 2003;10:261–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329–40.PubMedCrossRefGoogle Scholar
  56. 56.
    Gibson PB, Demus D, Noto R, Hudson W, Johnson LL. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol 2002;39:999–1004.PubMedCrossRefGoogle Scholar
  57. 57.
    Galassi AR, Azzarelli S, Tomaselli A, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001;88:101–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000;7:333–41.PubMedCrossRefGoogle Scholar
  59. 59.
    Soman P, Parsons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999;6:252–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, Bailey KR, Iskandrian AE. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Vanzetto G, Ormezzano O, Fagret D, et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 1999;100:1521–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Alkeylani A, Miller DD, Shaw LJ, et al. Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol 1998;81:293–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535–43.PubMedCrossRefGoogle Scholar
  64. 64.
    Olmos LI, Dakik H, Gordon R, et al. Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998;98:2679–86.PubMedCrossRefGoogle Scholar
  65. 65.
    Boyne TS, Koplan BA, Parsons WJ, et al. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 1997;79:270–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Snader CE, Marwick TH, Pashkow FJ, et al. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997;30:641–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996;28:447–54.PubMedCrossRefGoogle Scholar
  68. 68.
    Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiacrelated hospital admissions. J Am Coll Cardiol 1995;26:1202–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Kamal AM, Fattah AA, Pancholy S, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994;1:254–61.PubMedCrossRefGoogle Scholar
  70. 70.
    Machecourt J, Longere P, Fagret D, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994;23:1096–106.PubMedCrossRefGoogle Scholar
  71. 71.
    Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647–52.PubMedCrossRefGoogle Scholar
  72. 72.
    Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Poldermans D. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi single-photon emission computed tomography. Am J Cardiol 2003;91:264–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Patel AD, Abo-Auda WS, Davis JM, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003;92:146–51.PubMedCrossRefGoogle Scholar
  74. 74.
    Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:33–40.PubMedCrossRefGoogle Scholar
  75. 75.
    Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125–33.PubMedCrossRefGoogle Scholar
  76. 76.
    Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900–7.PubMedCrossRefGoogle Scholar
  77. 77.
    Schinkel AF, Elhendy A, van Domburg RT, et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 2003;91:408–11.PubMedCrossRefGoogle Scholar
  78. 78.
    Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Poldermans D. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi single-photon emission computed tomography. Am J Cardiol 2003;91:264–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Acampa W, Petretta M, Florimonte L, Mattera A, Cuocolo A. Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients. Am J Cardiol 2003;91:259–63.PubMedCrossRefGoogle Scholar
  80. 80.
    Schinkel AF, Elhendy A, Van Domburg RT, et al. Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up. Radiology 2002; 225:701–6.PubMedCrossRefGoogle Scholar
  81. 81.
    De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion singlephoton emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90:827–32.PubMedCrossRefGoogle Scholar
  82. 82.
    Bravo N, Gimenez M, Mejia S, Garcia-Velloso MJ, Coma-Canella I. Prognostic value of myocardial perfusion imaging with adenosine triphosphate. J Nucl Cardiol 2002;9:395–401.PubMedCrossRefGoogle Scholar
  83. 83.
    Schinkel AF, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease. J Nucl Med 2002;43:767–72.PubMedGoogle Scholar
  84. 84.
    Feola M, Biggi A, Ribichini F, et al. Predicting cardiac events with Tl201 dipyridamole myocardial scintigraphy in renal transplant recipients. J Nephrol 2002;15:48–53.PubMedGoogle Scholar
  85. 85.
    Hachamovitch R, Berman DS, Kiat H. et al. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Groutars RG, Verzijlbergen JF, Zwinderman AH, et al. Incremental prognostic value of myocardial SPET with dual-isotope rest (201)Tl/stress (99m)Tc-tetrofosmin. Eur J Nucl Med Mol Imaging 2002;29:46–52.PubMedCrossRefGoogle Scholar
  87. 87.
    Calnon DA, McGrath PD, Doss AL, et al. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol 2001;38:1511–7.PubMedCrossRefGoogle Scholar
  88. 88.
    Cottin Y, Rezaizadeh K, Touzery C, et al. Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting. Am Heart J 2001;141:999–1006.PubMedCrossRefGoogle Scholar
  89. 89.
    Kaminek M, Myslivecek M, Myslivecek M, et al. Prognostic value of myocardial perfusion tomographic imaging in patients after percutaneous transluminal coronary angioplasty. Clin Nucl Med 2000;25:775–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Amanullah AM, Berman DS, Kang X, et al. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography. Am Heart J 2000;140:456–62.PubMedCrossRefGoogle Scholar
  91. 91.
    Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025–32.PubMedCrossRefGoogle Scholar
  92. 92.
    Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, Kang X, Friedman J, Diamond GA. Incremental prognostic value of adenosine stress myocardial perfusion single photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426–33.PubMedCrossRefGoogle Scholar
  93. 93.
    Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905–14.PubMedCrossRefGoogle Scholar
  94. 94.
    Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34–44.PubMedCrossRefGoogle Scholar
  95. 95.
    Hachamovitch R, Berman DS, Kiat H, et al. Gender-related differences in clinical management after exercise nuclear testing. J Am Coll Cardiol 1995;26:1457–64.PubMedCrossRefGoogle Scholar
  96. 96.
    Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium- 99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–47.PubMedCrossRefGoogle Scholar
  97. 97.
    Gibbons RJ, Abrams J, Chatterjee K, et al; American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159–68.PubMedCrossRefGoogle Scholar
  98. 98.
    Thomas GS, Miyamoto MI, Morello AP III, et al. Technetium99m based myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: the Nuclear Utility in the Community (“NUC”) Study. J Am Coll Cardiol 2004;43:213–23.PubMedCrossRefGoogle Scholar
  99. 99.
    Maddahi J, Shaw LJ, Hendel RC, et al. Prediction of cardiovascular death and nonfatal myocardial infarction by stress Tc-99m tetrofosmin SPECT: results from a multicenter registry [abstract]. J Nucl Cardiol 2003;10;573.Google Scholar
  100. 100.
    Burns RJ, Gibbons RJ, Yi Q, et al; CORE Study Investigators. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30–6.PubMedCrossRefGoogle Scholar
  101. 101.
    Kroll D, Farah W, McKendall GR, Reinert SE, Johnson LL. Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction. Am J Cardiol 2001;87:381–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831–7.PubMedGoogle Scholar
  103. 103.
    Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035–42.PubMedCrossRefGoogle Scholar
  104. 104.
    Shaw LJ, Miller DD, Berman DS, Hachamovitch R. Clinical and economic outcomes assessment in nuclear cardiology. Q J Nucl Med 2000;44:138–52.PubMedGoogle Scholar
  105. 105.
    Abidov A, Bax JJ, Hayes SW, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818–25.PubMedCrossRefGoogle Scholar
  106. 106.
    Mieres JH, Shaw LJ, Hendel RC, et al; American Society of Nuclear Cardiology Task Force on Women and Heart Disease Writing Group on Perfusion Imaging in Women. A report of the American Society of Nuclear Cardiology Task Force on Women and Heart Disease (Writing Group on Perfusion Imaging in Women). J Nucl Cardiol 2003;10:95–101.PubMedCrossRefGoogle Scholar
  107. 107.
    Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.PubMedCrossRefGoogle Scholar
  108. 108.
    Vanzetto G, Halimi S, Hammoud T, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19–26.PubMedCrossRefGoogle Scholar
  109. 109.
    Marwick TH, Shaw LJ, Lauer MS, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Am J Med 1999;106:172–8.PubMedCrossRefGoogle Scholar
  110. 110.
    Amanullah AM, Berman DS, Erel J, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998;82:725–30.PubMedCrossRefGoogle Scholar
  111. 111.
    Zellweger MJ, Berman D, Shaw L, et al. Evaluation of patients after intervention. In: Poshost G, O’Rourke R, Berman DS, et al. editors. Imaging in cardiovascular medicine. Philadelphia: Lippincott Williams & Wilkins; 2000.Google Scholar
  112. 112.
    Alazraki NP, Krawczynska EG, Kosinski AS, et al. Prognostic value of Tl-201 SPECT for patients with multivessel coronary disease post-revascularization: results from the Emory angioplasty- surgery trial. Am J Cardiol 1999;84:1369–74.PubMedCrossRefGoogle Scholar
  113. 113.
    Lauer MS, Lytle B, Pashkow F, et al. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting. Lancet 1998;351:615–22.PubMedCrossRefGoogle Scholar
  114. 114.
    Hecht HS, Shaw RE, Bruce TR, et al. Usefulness of tomographic thallium-201 imaging for detection of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990;66:1314–8.PubMedCrossRefGoogle Scholar
  115. 115.
    Hecht HS, Shaw RE, Chin HL, et al. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991;17:670–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart F. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993;22:1446–54.PubMedCrossRefGoogle Scholar
  117. 117.
    Milan E, Zoccarato O, Terzi A, et al. Technetium-99m-sestamibi SPECT to detect restenosis after successful percutaneous coronary angioplasty. J Nucl Med 1996;37:1300–5.PubMedGoogle Scholar
  118. 118.
    Miller DD, Verani MS. Current status of myocardial perfusion imaging after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994;24:260–6.PubMedCrossRefGoogle Scholar
  119. 119.
    Breisblatt WM, Barnes JV, Weiland F, Spaccavento LJ. Incomplete revascularization in multivessel percutaneous transluminal coronary angioplasty: the role for stress thallium-201 imaging. J Am Coll Cardiol 1988;11:1183–90.PubMedCrossRefGoogle Scholar
  120. 120.
    Manyari DE, Knudtson M, Kloiber R, Roth D. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988;77:86–95.PubMedCrossRefGoogle Scholar
  121. 121.
    Hirzel HO, Nuesch K, Gruentzig AR, Luetolf UM. Short- and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy. Circulation 1981;63:1001–7.PubMedCrossRefGoogle Scholar
  122. 122.
    Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol 2001;37:144–52.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2004

Authors and Affiliations

  1. 1.Atlanta Cardiovascular Research InstituteAtlanta
  2. 2.University of Alabama at BirminghamBirmingham

Personalised recommendations